Edition:
United States

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
15 Dec 2017
Change (% chg)

$-0.01 (-1.48%)
Prev Close
$0.35
Open
$0.35
Day's High
$0.36
Day's Low
$0.34
Volume
96,976
Avg. Vol
193,252
52-wk High
$1.99
52-wk Low
$0.32

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Gary Jacob

70 2014 Chairman of the Board

James Sapirstein

54 2014 Chief Executive Officer, Director

John Cavan

58 2016 Chief Financial Officer

Robert Foster

58 2016 Chief Scientific Officer

Theresa Matkovits

49 2015 Senior Vice President—Drug Development